HLA-DRB1 and myeloid sarcoma: The HLA-DRB1 genotyping of MS patients reflects frequencies normally expected both in line with the Italian reference population (allefrequencies.net, last visit to website: 6 June 2023) [61] and with what is generally expected in MS patient cohorts [34,35].